These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 28901856)

  • 1. Recent Patents and Emerging Therapeutics on Ocular Inflammation and Allergy.
    Agrahari V; Aulgur Z; Thukral S; Dhall N; Conley R; Mitra AK
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):92-106. PubMed ID: 28901856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging therapies in allergic conjunctivitis and dry eye syndrome.
    Nye M; Rudner S; Bielory L
    Expert Opin Pharmacother; 2013 Aug; 14(11):1449-65. PubMed ID: 23822862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines in allergic conjunctivitis.
    Erdinest N; London N; Solomon A
    Curr Opin Allergy Clin Immunol; 2020 Oct; 20(5):516-527. PubMed ID: 32739979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergic conjunctivitis and uveitis models: reappraisal with some marketed drugs.
    Khosravi E; Elena PP; Hariton C
    Inflamm Res; 1995 Jan; 44(1):47-54. PubMed ID: 7664029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of ocular inflammatory conditions with loteprednol etabonate.
    Pavesio CE; Decory HH
    Br J Ophthalmol; 2008 Apr; 92(4):455-9. PubMed ID: 18245274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current market trends in anterior ocular inflammatory disease landscape.
    Khan RS; Rizvi S; Syed BA; Bielory L
    Curr Opin Allergy Clin Immunol; 2019 Oct; 19(5):503-509. PubMed ID: 31232860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergic conjunctivitis: the evolution of therapeutic options.
    Bielory L
    Allergy Asthma Proc; 2012; 33(2):129-39. PubMed ID: 22525389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loteprednol etabonate for inflammatory conditions of the anterior segment of the eye: twenty years of clinical experience with a retrometabolically designed corticosteroid.
    Comstock TL; Sheppard JD
    Expert Opin Pharmacother; 2018 Mar; 19(4):337-353. PubMed ID: 29430976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future directions in therapeutic interventions for conjunctival inflammatory disorders.
    Pflugfelder SC; Stern ME
    Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):450-3. PubMed ID: 17873588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current options and emerging therapies for anterior ocular inflammatory disease.
    Syed BA; Kumar S; Bielory L
    Curr Opin Allergy Clin Immunol; 2014 Oct; 14(5):485-9. PubMed ID: 25102104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Importance of Preventing and Managing Tear Dysfunction Syndrome in Allergic Conjunctivitis and How to Tackle This Problem.
    Montero-Iruzubieta J; Sanchez Hernandez MC; Dávila I; Leceta A
    J Investig Allergol Clin Immunol; 2023 Dec; 33(6):439-445. PubMed ID: 38095493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular allergy and dry eye syndrome.
    Bielory L
    Curr Opin Allergy Clin Immunol; 2004 Oct; 4(5):421-4. PubMed ID: 15349042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular Emergencies: Red Eye.
    Tarff A; Behrens A
    Med Clin North Am; 2017 May; 101(3):615-639. PubMed ID: 28372717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging drugs for ocular allergy.
    Leonardi A
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):505-20. PubMed ID: 16083326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavonoid and cannabinoid impact on the ocular surface.
    Bielory L; Tabliago NRA
    Curr Opin Allergy Clin Immunol; 2020 Oct; 20(5):482-492. PubMed ID: 32796166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release of an HDAC inhibitor for reduction of inflammation in dry eye disease.
    Ratay ML; Balmert SC; Bassin EJ; Little SR
    Acta Biomater; 2018 Apr; 71():261-270. PubMed ID: 29526828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic complications with laser-assisted in-situ keratomileusis.
    Bielory BP; O'Brien TP
    Curr Opin Allergy Clin Immunol; 2011 Oct; 11(5):483-91. PubMed ID: 21822133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in the diagnosis and therapy for diseases of the ocular surface: dry eye and ocular allergies].
    Messmer EM; Benitez del Castello J; Lambiase A; Doan S
    Klin Monbl Augenheilkd; 2006 Aug; 223(8):643-9. PubMed ID: 16927218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-inflammatory effects of therapies for ocular allergy.
    Mantelli F; Calder VL; Bonini S
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):786-93. PubMed ID: 24044620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dry eye syndrome and allergic conjunctivitis--epidemics of XXI century--diagnostic problems and management].
    Kubicka-Trzaska A; Romanowska-Dixon B
    Przegl Lek; 2009; 66(11):967-71. PubMed ID: 20297640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.